Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial.
Masson S, Latini R, Carbonieri E, Moretti L, Rossi MG, Ciricugno S, Milani V, Marchioli R, Struck J, Bergmann A, Maggioni AP, Tognoni G, Tavazzi L; GISSI-HF Investigators. Masson S, et al. Among authors: milani v. Eur J Heart Fail. 2010 Apr;12(4):338-47. doi: 10.1093/eurjhf/hfp206. Epub 2010 Jan 22. Eur J Heart Fail. 2010. PMID: 20097683 Free article. Clinical Trial.
Risk factors for inadequate bowel preparation in patients using high- and low-volume cleansing products.
Occhipinti V, Soriani P, Vavassori S, Annunziata ML, Bagolini F, Cavallaro F, Lagoussis P, Milani V, Rondonotti E, Spina L, Vecchi M, Pastorelli L, Tontini GE. Occhipinti V, et al. Among authors: milani v. Eur J Gastroenterol Hepatol. 2023 Feb 1;35(2):159-166. doi: 10.1097/MEG.0000000000002467. Epub 2022 Nov 8. Eur J Gastroenterol Hepatol. 2023. PMID: 36574306
Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial.
Masson S, Latini R, Milani V, Moretti L, Rossi MG, Carbonieri E, Frisinghelli A, Minneci C, Valisi M, Maggioni AP, Marchioli R, Tognoni G, Tavazzi L; GISSI-HF Investigators. Masson S, et al. Among authors: milani v. Circ Heart Fail. 2010 Jan;3(1):65-72. doi: 10.1161/CIRCHEARTFAILURE.109.881805. Epub 2009 Oct 22. Circ Heart Fail. 2010. PMID: 19850697 Clinical Trial.
Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice.
Rischio and Prevenzione Investigators. Rischio and Prevenzione Investigators. Trials. 2010 May 28;11:68. doi: 10.1186/1745-6215-11-68. Trials. 2010. PMID: 20509875 Free PMC article. Clinical Trial.
Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial.
Røysland R, Masson S, Omland T, Milani V, Bjerre M, Flyvbjerg A, Di Tano G, Misuraca G, Maggioni AP, Tognoni G, Tavazzi L, Latini R; GISSI-HF Investigators. Røysland R, et al. Among authors: milani v. Am Heart J. 2010 Aug;160(2):286-93. doi: 10.1016/j.ahj.2010.05.015. Am Heart J. 2010. PMID: 20691834 Clinical Trial.
Adiponectin in chronic heart failure: influence of diabetes and genetic variants.
Masson S, Gori F, Latini R, Milani V, Flyvbjerg A, Frystyk J, Crociati L, Pietri S, Vago T, Barlera S, Maggioni AP, Tognoni G, Tavazzi L, Omland T, Franzosi MG; GISSI-HF Investigators. Masson S, et al. Among authors: milani v. Eur J Clin Invest. 2011 Dec;41(12):1330-8. doi: 10.1111/j.1365-2362.2011.02548.x. Epub 2011 May 30. Eur J Clin Invest. 2011. PMID: 21623778 Clinical Trial.
107 results